Literature DB >> 24794724

Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging.

A A Parkhitko1, O O Favorova, D I Khabibullin, V N Anisimov, E P Henske.   

Abstract

Serine/threonine protein kinase mTOR regulates the maintenance of cellular homeostasis by coordinating transcription, translation, metabolism, and autophagy with availability of amino acids, growth factors, ATP, and oxygen. The mTOR kinase is a component of two protein complexes, mTORC1 and mTORC2, which are different in their composition and regulate different cellular processes. An uncontrolled activation of the mTOR kinase is observed in cells of the majority of tumors, as well as in diabetes and neurodegenerative and some other diseases. At present, inhibitors of the kinase complex mTORC1 are undergoing clinical trials. This review focuses on different aspects of the regulation of the mTORC1 and mTORC2 complexes, on their role in the regulation of protein synthesis, metabolism, and autophagy, as well as on using mTOR inhibitors for treatment of tumors and slowing of aging.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24794724     DOI: 10.1134/S0006297914020023

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  14 in total

1.  Transient overexpression of Werner protein rescues starvation induced autophagy in Werner syndrome cells.

Authors:  Jyotirindra Maity; Vilhelm A Bohr; Aparna Laskar; Parimal Karmakar
Journal:  Biochim Biophys Acta       Date:  2014-09-23

Review 2.  Do metformin a real anticarcinogen? A critical reappraisal of experimental data.

Authors:  Vladimir N Anisimov
Journal:  Ann Transl Med       Date:  2014-06

3.  Sex differences in aging, life span and spontaneous tumorigenesis in 129/Sv mice neonatally exposed to metformin.

Authors:  Vladimir N Anisimov; Irina G Popovich; Mark A Zabezhinski; Peter A Egormin; Maria N Yurova; Anna V Semenchenko; Margarita L Tyndyk; Andrey V Panchenko; Alexandr P Trashkov; Andrey G Vasiliev; Nikolai V Khaitsev
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  microRNA-496 - A new, potentially aging-relevant regulator of mTOR.

Authors:  Claudia Rubie; Kathrin Kölsch; Beata Halajda; Hermann Eichler; Stefan Wagenpfeil; Klaus Roemer; Matthias Glanemann
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

5.  Different anaesthesia methods affect the development of hepatoblastoma after platelet activation.

Authors:  Guoxiong Fei; Meili Cao; Chunlin Ge; Yan Xie
Journal:  Int J Exp Pathol       Date:  2021-01-07       Impact factor: 1.925

6.  A genetic model of methionine restriction extends Drosophila health- and lifespan.

Authors:  Andrey A Parkhitko; Lin Wang; Elizabeth Filine; Patrick Jouandin; Dmitry Leshchiner; Richard Binari; John M Asara; Joshua D Rabinowitz; Norbert Perrimon
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-05       Impact factor: 11.205

Review 7.  Targeting metabolic pathways for extension of lifespan and healthspan across multiple species.

Authors:  Andrey A Parkhitko; Elizabeth Filine; Stephanie E Mohr; Alexey Moskalev; Norbert Perrimon
Journal:  Ageing Res Rev       Date:  2020-10-05       Impact factor: 11.788

8.  Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway.

Authors:  Pierre-Emmanuel Joubert; Kenneth Stapleford; Florence Guivel-Benhassine; Marco Vignuzzi; Olivier Schwartz; Matthew L Albert
Journal:  PLoS Pathog       Date:  2015-08-28       Impact factor: 6.823

9.  Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.

Authors:  V Makovski; J Jacob-Hirsch; C Gefen-Dor; B Shai; M Ehrlich; G Rechavi; Y Kloog
Journal:  Cell Death Dis       Date:  2014-12-04       Impact factor: 8.469

10.  MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1.

Authors:  Shaohua Xu; Guang-Bo Fu; Zhen Tao; Jun OuYang; Fanfei Kong; Bing-Hua Jiang; Xiaoping Wan; Ke Chen
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.